The largest database of trusted experimental protocols

Snail sirna

Manufactured by Santa Cruz Biotechnology
Sourced in France

Snail siRNA is a laboratory reagent designed for the silencing of the Snail gene in experimental settings. It is a short, double-stranded RNA molecule that can specifically target and degrade Snail mRNA, thereby reducing the expression of the Snail protein. This product is intended for use in cell-based experiments and research applications where the role of the Snail gene is under investigation.

Automatically generated - may contain errors

2 protocols using snail sirna

1

Hepatic Ischemia-Reperfusion Injury Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used an established mouse model that utilized warm hepatic ischemia followed by reperfusion.2 (link) Mice were injected with heparin (100 U/kg), and an atraumatic clip was used to interrupt the arterial/portal venous blood supply to the cephalad liver lobes. After 90 min of ischemia, the clip was removed, and mice were sacrificed after 6 h of reperfusion. Some animals were injected via the tail vein with bone marrow-derived macrophages (BMMs, 5 × 106 cells in PBS/mouse) transfected with lentivirus-expressing HSF1 (Lv-HSF1) 24 h prior to ischemia, and some animals were injected i.v. with Snail siRNA or nonspecific (control) siRNA (2 mg/kg) (Santa Cruz Biotechnology, CA) mixed with mannose-conjugated polymers (Polyplus transfection™, Illkirch, France) at a ratio defined according to the manufacturer’s instructions 4 h prior to ischemia, as described.2 (link) Some animals were injected i.v. with recombinant JAG1 (0.5 mg/kg, R&D Systems) or PBS 1 h prior to ischemia.
+ Open protocol
+ Expand
2

ALKBH5 and Snail Regulation in SK-OV3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Snail siRNA was purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and ALKBH5 siRNA (CCATGACGTCCCGGGACAACTATAA) was constructed and obtained from Invitrogen. siRNAs (40 nM diluted in 1 mL Opti-MEM) were transfected to SK-OV3 cells using Lipofectamine RNAiMAX (#13778150, Invitrogen). The plasmid of wild-type (pENTER-ALKBH5) and mutated ALKBH5-H204A (pENTER-ALKBH5-H204A) was obtained from WZ Biosciences Inc, while plasmid of wild-type (pSLenti-Snail) and mutated Snail (pSLenti-Snail-mut, adenosine bases in m6A consensus sites replaced by cytosine nucleotides) was constructed and obtained from OBiO Technology. Plasmid (2 µg diluted in 1 mL Opti-MEM) was transfected to SK-OV3 cells using Lipofectamine 3000 Transfection Reagent (#L3000015, Invitrogen). The shRNA of human ALKBH5 was cloned into a lentiviral vector (pLent-3in1-shRNA-CMV-copGFP-P2A-Puro) for knockdown. Sequences of the shRNAs were as followed, stably transfected SK-OV3 cells were selected using puromycin (#ST551, Beyotime, China): siRNA1: GTCCTTCTTTAGCGACTCT; siRNA2: CCATGACGTCCCGGGACAACTATAA; siRNA3: GCTCAGTGGATATGCTGCTGATGAA.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!